Science & Technology
Identification of Mixed NOP/mu partial agonists as lead compounds for treatment ofmethamphetamine use disorder
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41DA057430-01
Award Ceiling
$320K
Award Floor
$320K
Close Date
May 14, 2024
Total Funding
$320K
Expected Awards
1
Posted Date
May 15, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R41DA057430-01
Description
STTR Phase Phase I award: "Identification of Mixed NOP/mu partial agonists as lead compounds for treatment ofmethamphetamine use disorder" awarded to PHOENIX PHARMALABS, INC. in WOODS CROSS, Utah. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $319,983. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.